New Zealand vs Norway: Avoidable mortality
Avoidable mortality over time
- New Zealand
- Norway
How they compare
New Zealand currently reports 8,444 Deaths against 8,381 Deaths in Norway, a difference of 63 Deaths.
The two have swapped places 2 times across 17 shared years of data; in 2000 it was Norway ahead.
New Zealand ranks 32nd and Norway ranks 34th of 36 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8,511 Deaths | 8,960 Deaths | 448.9 Deaths | Norway |
| 2010s | 8,185 Deaths | 8,365 Deaths | 180.14 Deaths | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, New Zealand or Norway?
- New Zealand, at 8,444 Deaths against 8,381 Deaths in Norway as of 2020.
- What is the difference in avoidable mortality between New Zealand and Norway?
- 63 Deaths, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Norway?
- 17 years are reported by both, from 2000 to 2016.
- How do New Zealand and Norway rank globally for avoidable mortality?
- New Zealand ranks 32nd and Norway ranks 34th of 36 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.